Selected research
Market Analysis & Forecast
Global AI Pathology Software Market Analysis and Forecast 2026-2032
Market perspective
The global AI Pathology Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for AI Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for AI Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for AI Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for AI Pathology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of AI Pathology Software include Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, Visiopharm A/S and Tempus AI, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for AI Pathology Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of AI Pathology Software, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Pathology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AI Pathology Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Pathology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Pathology Software revenue, projected growth trends, production technology, application and end-user industry.
AI Pathology Software Segment by Company
Aiforia Technologies Plc
Ibex Medical Analytics Ltd.
Proscia Inc.
Philips
Roche Diagnostics International Ltd
Leica Biosystems Nussloch GmbH
Fujifilm Holdings Corporation
Visiopharm A/S
Tempus AI, Inc.
Yitu Technology Co., Ltd.
Deepwise Healthcare Technology Co., Ltd.
PathAI, Inc.
Paige AI, Inc.
Indica Labs
AI Pathology Software Segment by Type
Histopathology AI Analysis Software
Cytopathology AI Analysis Software
Immunohistochemistry AI Analysis Software
Molecular Pathology AI Analysis Software
AI Pathology Software Segment by Application
Hospital Pathology Department
Third-party Medical Testing Laboratory
Pharmaceutical R&D
AI Pathology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI Pathology Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI Pathology Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Pathology Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Histopathology AI Analysis Software
- Cytopathology AI Analysis Software
- Immunohistochemistry AI Analysis Software
- Molecular Pathology AI Analysis Software
Applications
- Hospital Pathology Department
- Third-party Medical Testing Laboratory
- Pharmaceutical R&D
Companies covered
- Aiforia Technologies Plc
- Ibex Medical Analytics Ltd.
- Proscia Inc.
- Philips
- Roche Diagnostics International Ltd
- Leica Biosystems Nussloch GmbH
- Fujifilm Holdings Corporation
- Visiopharm A/S
- Tempus AI, Inc.
- Yitu Technology Co., Ltd.
- Deepwise Healthcare Technology Co., Ltd.
- PathAI, Inc.
- Paige AI, Inc.
- Indica Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 AI Pathology Software Market by Type
- 1.2.1 Global AI Pathology Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Histopathology AI Analysis Software
- 1.2.3 Cytopathology AI Analysis Software
- 1.2.4 Immunohistochemistry AI Analysis Software
- 1.2.5 Molecular Pathology AI Analysis Software
- 1.3 AI Pathology Software Market by Application
- 1.3.1 Global AI Pathology Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pathology Department
- 1.3.3 Third-party Medical Testing Laboratory
- 1.3.4 Pharmaceutical R&D
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Pathology Software Market Dynamics
- 2.1 AI Pathology Software Industry Trends
- 2.2 AI Pathology Software Industry Drivers
- 2.3 AI Pathology Software Industry Opportunities and Challenges
- 2.4 AI Pathology Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global AI Pathology Software Market Perspective (2021-2032)
- 3.2 Global AI Pathology Software Growth Trends by Region
- 3.2.1 Global AI Pathology Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global AI Pathology Software Market Size by Region (2021-2026)
- 3.2.3 Global AI Pathology Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global AI Pathology Software Revenue by Players
- 4.1.1 Global AI Pathology Software Revenue by Players (2021-2026)
- 4.1.2 Global AI Pathology Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global AI Pathology Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global AI Pathology Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global AI Pathology Software Key Players Headquarters & Area Served
- 4.4 Global AI Pathology Software Players, Product Type & Application
- 4.5 Global AI Pathology Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global AI Pathology Software Market CR5 and HHI
- 4.6.3 2025 AI Pathology Software Tier 1, Tier 2, and Tier 3
5 AI Pathology Software Market Size by Type
- 5.1 Global AI Pathology Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global AI Pathology Software Revenue by Type (2021-2032)
- 5.3 Global AI Pathology Software Revenue Market Share by Type (2021-2032)
6 AI Pathology Software Market Size by Application
- 6.1 Global AI Pathology Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global AI Pathology Software Revenue by Application (2021-2032)
- 6.3 Global AI Pathology Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Aiforia Technologies Plc
- 7.1.1 Aiforia Technologies Plc Company Information
- 7.1.2 Aiforia Technologies Plc Business Overview
- 7.1.3 Aiforia Technologies Plc AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.1.4 Aiforia Technologies Plc AI Pathology Software Product Portfolio
- 7.1.5 Aiforia Technologies Plc Recent Developments
- 7.2 Ibex Medical Analytics Ltd.
- 7.2.1 Ibex Medical Analytics Ltd. Company Information
- 7.2.2 Ibex Medical Analytics Ltd. Business Overview
- 7.2.3 Ibex Medical Analytics Ltd. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.2.4 Ibex Medical Analytics Ltd. AI Pathology Software Product Portfolio
- 7.2.5 Ibex Medical Analytics Ltd. Recent Developments
- 7.3 Proscia Inc.
- 7.3.1 Proscia Inc. Company Information
- 7.3.2 Proscia Inc. Business Overview
- 7.3.3 Proscia Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.3.4 Proscia Inc. AI Pathology Software Product Portfolio
- 7.3.5 Proscia Inc. Recent Developments
- 7.4 Philips
- 7.4.1 Philips Company Information
- 7.4.2 Philips Business Overview
- 7.4.3 Philips AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.4.4 Philips AI Pathology Software Product Portfolio
- 7.4.5 Philips Recent Developments
- 7.5 Roche Diagnostics International Ltd
- 7.5.1 Roche Diagnostics International Ltd Company Information
- 7.5.2 Roche Diagnostics International Ltd Business Overview
- 7.5.3 Roche Diagnostics International Ltd AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.5.4 Roche Diagnostics International Ltd AI Pathology Software Product Portfolio
- 7.5.5 Roche Diagnostics International Ltd Recent Developments
- 7.6 Leica Biosystems Nussloch GmbH
- 7.6.1 Leica Biosystems Nussloch GmbH Company Information
- 7.6.2 Leica Biosystems Nussloch GmbH Business Overview
- 7.6.3 Leica Biosystems Nussloch GmbH AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.6.4 Leica Biosystems Nussloch GmbH AI Pathology Software Product Portfolio
- 7.6.5 Leica Biosystems Nussloch GmbH Recent Developments
- 7.7 Fujifilm Holdings Corporation
- 7.7.1 Fujifilm Holdings Corporation Company Information
- 7.7.2 Fujifilm Holdings Corporation Business Overview
- 7.7.3 Fujifilm Holdings Corporation AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.7.4 Fujifilm Holdings Corporation AI Pathology Software Product Portfolio
- 7.7.5 Fujifilm Holdings Corporation Recent Developments
- 7.8 Visiopharm A/S
- 7.8.1 Visiopharm A/S Company Information
- 7.8.2 Visiopharm A/S Business Overview
- 7.8.3 Visiopharm A/S AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.8.4 Visiopharm A/S AI Pathology Software Product Portfolio
- 7.8.5 Visiopharm A/S Recent Developments
- 7.9 Tempus AI, Inc.
- 7.9.1 Tempus AI, Inc. Company Information
- 7.9.2 Tempus AI, Inc. Business Overview
- 7.9.3 Tempus AI, Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.9.4 Tempus AI, Inc. AI Pathology Software Product Portfolio
- 7.9.5 Tempus AI, Inc. Recent Developments
- 7.10 Yitu Technology Co., Ltd.
- 7.10.1 Yitu Technology Co., Ltd. Company Information
- 7.10.2 Yitu Technology Co., Ltd. Business Overview
- 7.10.3 Yitu Technology Co., Ltd. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.10.4 Yitu Technology Co., Ltd. AI Pathology Software Product Portfolio
- 7.10.5 Yitu Technology Co., Ltd. Recent Developments
- 7.11 Deepwise Healthcare Technology Co., Ltd.
- 7.11.1 Deepwise Healthcare Technology Co., Ltd. Company Information
- 7.11.2 Deepwise Healthcare Technology Co., Ltd. Business Overview
- 7.11.3 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.11.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product Portfolio
- 7.11.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments
- 7.12 PathAI, Inc.
- 7.12.1 PathAI, Inc. Company Information
- 7.12.2 PathAI, Inc. Business Overview
- 7.12.3 PathAI, Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.12.4 PathAI, Inc. AI Pathology Software Product Portfolio
- 7.12.5 PathAI, Inc. Recent Developments
- 7.13 Paige AI, Inc.
- 7.13.1 Paige AI, Inc. Company Information
- 7.13.2 Paige AI, Inc. Business Overview
- 7.13.3 Paige AI, Inc. AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.13.4 Paige AI, Inc. AI Pathology Software Product Portfolio
- 7.13.5 Paige AI, Inc. Recent Developments
- 7.14 Indica Labs
- 7.14.1 Indica Labs Company Information
- 7.14.2 Indica Labs Business Overview
- 7.14.3 Indica Labs AI Pathology Software Revenue and Gross Margin (2021-2026)
- 7.14.4 Indica Labs AI Pathology Software Product Portfolio
- 7.14.5 Indica Labs Recent Developments
8 North America
- 8.1 North America AI Pathology Software Revenue (2021-2032)
- 8.2 North America AI Pathology Software Revenue by Type (2021-2032)
- 8.2.1 North America AI Pathology Software Revenue by Type (2021-2026)
- 8.2.2 North America AI Pathology Software Revenue by Type (2027-2032)
- 8.3 North America AI Pathology Software Revenue Share by Type (2021-2032)
- 8.4 North America AI Pathology Software Revenue by Application (2021-2032)
- 8.4.1 North America AI Pathology Software Revenue by Application (2021-2026)
- 8.4.2 North America AI Pathology Software Revenue by Application (2027-2032)
- 8.5 North America AI Pathology Software Revenue Share by Application (2021-2032)
- 8.6 North America AI Pathology Software Revenue by Country
- 8.6.1 North America AI Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America AI Pathology Software Revenue by Country (2021-2026)
- 8.6.3 North America AI Pathology Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe AI Pathology Software Revenue (2021-2032)
- 9.2 Europe AI Pathology Software Revenue by Type (2021-2032)
- 9.2.1 Europe AI Pathology Software Revenue by Type (2021-2026)
- 9.2.2 Europe AI Pathology Software Revenue by Type (2027-2032)
- 9.3 Europe AI Pathology Software Revenue Share by Type (2021-2032)
- 9.4 Europe AI Pathology Software Revenue by Application (2021-2032)
- 9.4.1 Europe AI Pathology Software Revenue by Application (2021-2026)
- 9.4.2 Europe AI Pathology Software Revenue by Application (2027-2032)
- 9.5 Europe AI Pathology Software Revenue Share by Application (2021-2032)
- 9.6 Europe AI Pathology Software Revenue by Country
- 9.6.1 Europe AI Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe AI Pathology Software Revenue by Country (2021-2026)
- 9.6.3 Europe AI Pathology Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China AI Pathology Software Revenue (2021-2032)
- 10.2 China AI Pathology Software Revenue by Type (2021-2032)
- 10.2.1 China AI Pathology Software Revenue by Type (2021-2026)
- 10.2.2 China AI Pathology Software Revenue by Type (2027-2032)
- 10.3 China AI Pathology Software Revenue Share by Type (2021-2032)
- 10.4 China AI Pathology Software Revenue by Application (2021-2032)
- 10.4.1 China AI Pathology Software Revenue by Application (2021-2026)
- 10.4.2 China AI Pathology Software Revenue by Application (2027-2032)
- 10.5 China AI Pathology Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia AI Pathology Software Revenue (2021-2032)
- 11.2 Asia AI Pathology Software Revenue by Type (2021-2032)
- 11.2.1 Asia AI Pathology Software Revenue by Type (2021-2026)
- 11.2.2 Asia AI Pathology Software Revenue by Type (2027-2032)
- 11.3 Asia AI Pathology Software Revenue Share by Type (2021-2032)
- 11.4 Asia AI Pathology Software Revenue by Application (2021-2032)
- 11.4.1 Asia AI Pathology Software Revenue by Application (2021-2026)
- 11.4.2 Asia AI Pathology Software Revenue by Application (2027-2032)
- 11.5 Asia AI Pathology Software Revenue Share by Application (2021-2032)
- 11.6 Asia AI Pathology Software Revenue by Country
- 11.6.1 Asia AI Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia AI Pathology Software Revenue by Country (2021-2026)
- 11.6.3 Asia AI Pathology Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA AI Pathology Software Revenue (2021-2032)
- 12.2 SAMEA AI Pathology Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA AI Pathology Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA AI Pathology Software Revenue by Type (2027-2032)
- 12.3 SAMEA AI Pathology Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA AI Pathology Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA AI Pathology Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA AI Pathology Software Revenue by Application (2027-2032)
- 12.5 SAMEA AI Pathology Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA AI Pathology Software Revenue by Country
- 12.6.1 SAMEA AI Pathology Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA AI Pathology Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA AI Pathology Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst